Isabel CHILLÓN

This meeting aims to share our research on the broad field of RNA, from RNA expression to non-coding RNAs, RNA modifications, translation, and RNA metabolism, covering both basic and applied research.

I would like to invite you to register and attend the 9th RNA Occ' workshop that we are organizing on June 17th in Montpellier. This year's invited speaker is Jorge Ferrer, from the Centre for Genomic Regulation, Barcelona. rnaocc.sciencesconf.org/?forward-actio…

There isn't a single life to live; there are multiple possible lives waiting to be experienced. I wish you all a peaceful Christmas and a bright new year.

2024 has been a tough year. But despite the low moments, I've kept working hard, sowing seeds for the future. 2025 will give answers to two important questions, professionally and personally, and whatever those will be, I will embrace them with openness and acceptance.

A big hurrah to the organizers, @LopezIisabel & @JYRoignant!

The CIG Symposium "Novelties in the RNA World," in Lausanne, has been a refreshing breath of fresh air. I could receive expert feedback from my talk on lncRNAs, catch up with colleagues, and at the top of the top: meet the Nobel-prize winner, Tom Cech, my "scientific grandpa".

Are you an RNA-aficionado Master's student looking to advance non-coding RNA research to the next scientific level? Apply for a PhD in our lab, where RNA structure meets function and basic research leads to clinical applications. Apply by May 13th: lnkd.in/eRUxebfi

Each of these molecular traits has the potential to become a therapeutic target to affect gene expression, especially for disease genes where traditional approaches have failed.

RNA is a complex molecule able to adopt intricate secondary and tertiary structures with only four different nucleotides! Those can contain multiple post-transcriptional modifications, which provide novel physicochemical properties affecting RNA-protein interactions.

RNA research is gaining momentum, and funding agencies, including European ones, should invest in it for the benefit of all. Messenger RNA, which constitutes the COVID-19 vaccine, and non-coding RNAs, like my favorite long non-coding RNAs, are the future of medicine.

How do you break the gap between science and society?

Last Christmas, we did science at home. The young (and not so young) ones learned how to use a micropipette and discussed the scales at which molecular biology takes place. Their questions reflected how we, as scientists, are seen and understood (or not 🫣) by others.

Participating in the DECLICS initiative #declics2023 in Montpellier, which promotes exchanges between high school students and researchers. Great idea; lots of fun!

It was a nice exchange in which I learned the reality of the everyday fight against cancer from patients and doctors. It was also important for me to have my mom's presence, a breast cancer survivor, and feel that science and medicine have no borders and a single language.

Today, it´s the International Day Against Breast Cancer. From Montpellier, I want to thank La Ligue Contre Le Cancer for supporting my research, symbolized during last Saturday's Cérémonie de Remise de Chèques in Perpignan.

@Marcia_lincRlab @EMBLGrenoble @KariSabalette @epifiz87 Great job!

Principles of #lncRNA structure-functional connections emerging! Our new work in press shows how lncRNAs use non-canonical #GUwobble motifs to shape their molecular structure and define their function doi.org/10.1016/j.bioc… @EMBLGrenoble @KariSabalette @epifiz87 @elsbiochimie

I am grateful for the chance to present my work on the therapeutic possibilities of the Meg3 lncRNA and establish so promising connections with great people from both academia and pharma. Looking forward to participating in future editions!

It has been four inspiring days at the #EMBOnoncodingRNA in beautiful Poznan. My congratulations to the organizers Rory Johnson @Goldlab and @buszczynska for an incredible job.